The efficacy and safety of ciprofol and propofol in patients undergoing colonoscopy: A double-blind, randomized, controlled trial

被引:2
|
作者
Gao, Shi-Hui [1 ,2 ]
Tang, Qian-Qian [1 ,2 ]
Wang, Chang-Ming [2 ]
Guan, Zhan-Ying [3 ]
Wang, Ling-Ling [1 ,2 ]
Zhang, Jing [2 ]
Yan, Zeng-Long [4 ]
机构
[1] Dalian Med Univ, Dalian, Peoples R China
[2] China Med Univ, Peoples Hosp Liaoning Prov, Peoples Hosp, Dept Anesthesiol, 33 Wenyi Rd, Shenyang 110016, Peoples R China
[3] Jinqiu Hosp Liaoning Prov, Dept Anesthesiol, Shenyang, Peoples R China
[4] China Med Univ, Peoples Hosp, Liao Ning Provical Peoples Hosp, Dept Extraskeletal Surg 3, Shenyang, Peoples R China
关键词
Ciprofol; Propofol; Colonoscopy; Sedation; SEDATION; COMBINATION; ANESTHESIA;
D O I
10.1016/j.jclinane.2024.111474
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Study objective: Propofol is a commonly utilized anesthetic for painless colonoscopy, but its usage is occasionally limited due to its potential side effects, including cardiopulmonary suppression and injection pain. To address this limitation, the novel compound ciprofol has been proposed as a possible alternative for propofol. This study sought to determine whether there are any differences in the safety and efficacy of propofol and ciprofol for painless colonoscopy. Design: Randomized clinical trial. Setting: Single-centre, class A tertiary hospital, November 2021 to November 2022. Patients: Adult, American Society of Anesthesiologists Physical Status I to II and body mass index of 18 to 30 kg m(-2) patients scheduled to undergo colonoscopy. Interventions: Consecutive patients were randomly allocated in a 1:1 ratio to receive sedation for colonoscopy with ciprofol (group C) or propofol (group P). Measurements: The primary outcome was the success rate of colonoscopy. The secondary outcomes were onset time of sedation, operation time, recovery time and discharge time, patients and endoscopists satisfaction, side effects (e.g. injection pain, myoclonus, drowsiness, dizziness, procedure recall, nausea and vomiting) and incidence rate of cardiopulmonary adverse events. Main results: No significant difference was found in the success rate of colonoscopy between the two groups (ciprofol 96.3% vs. propofol 97.6%; mean difference - 1.2%, 95% CI: -6.5% to 4.0%, P = 0.650). However, group C showed prolonged sedation (63.4 vs. 54.8 s, P < 0.001) and fully alert times (9 vs 8 min, P = 0.013), as well as reduced incidences of injection pain (0 vs. 40.2%, P < 0.001), respiratory depression (2.4% vs. 13.4%, P = 0.021) and hypotension (65.9% vs. 80.5%, P = 0.034). Patients satisfaction was also higher in Group C (10 vs 9, P < 0.001). Conclusions: Ciprofol can be used independently for colonoscopy. When comparing the sedation efficacy of ciprofol and propofol, a 0.4 mg kg(-1) dose of ciprofol proved to be equal to a 2.0 mg kg(-1) dose of propofol, with fewer side effects and greater patient satisfaction during the procedure.
引用
下载
收藏
页数:7
相关论文
共 50 条
  • [31] Efficacy and safety of subanesthetic doses of esketamine combined with propofol in painless gastrointestinal endoscopy: a prospective, double-blind, randomized controlled trial
    Yongtong Zhan
    Shuqing Liang
    Zecheng Yang
    Qichen Luo
    Shuai Li
    Jiamin Li
    Zhaojia Liang
    Yalan Li
    BMC Gastroenterology, 22
  • [32] Efficacy and safety of subanesthetic doses of esketamine combined with propofol in painless gastrointestinal endoscopy: a prospective, double-blind, randomized controlled trial
    Zhan, Yongtong
    Liang, Shuqing
    Yang, Zecheng
    Luo, Qichen
    Li, Shuai
    Li, Jiamin
    Liang, Zhaojia
    Li, Yalan
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [33] Comparison of propofol-nalbuphine and propofol-fentanyl sedation for patients undergoing endoscopic retrograde cholangiopancreatography: a double-blind, randomized controlled trial
    Wang, Peiqi
    Chen, Yan
    Guo, Ying
    Cao, Jiangbei
    Wang, Hong
    Mi, Weidong
    Xu, Longhe
    BMC ANESTHESIOLOGY, 2022, 22 (01)
  • [34] A comparison of anesthetic regimens using etomidate and propofol in patients undergoing first-trimester abortions: double-blind, randomized clinical trial of safety and efficacy
    Wu, Jing
    Yao, Shanglong
    Wu, Zhouyang
    Wu, Zhiling
    Chu, Shujuan
    Xia, Geqing
    Deng, Feitao
    CONTRACEPTION, 2013, 87 (01) : 55 - 62
  • [35] Comparison of propofol-nalbuphine and propofol-fentanyl sedation for patients undergoing endoscopic retrograde cholangiopancreatography: a double-blind, randomized controlled trial
    Peiqi Wang
    Yan Chen
    Ying Guo
    Jiangbei Cao
    Hong Wang
    Weidong Mi
    Longhe Xu
    BMC Anesthesiology, 22
  • [36] Safety and efficacy of remimazolam besylate in patients undergoing colonoscopy: A multicentre, single-blind, randomized, controlled, phase III trial
    Wang, Ximei
    Hu, Xiaolei
    Bai, Nianyue
    Li, Lie
    Zhang, Min
    Cheng, Zhigang
    Guo, Qulian
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [37] Study on the effectiveness and safety of ciprofol in anesthesia in gynecological day surgery: a randomized double-blind controlled study
    Man, Yan
    Xiao, Hongyi
    Zhu, Teng
    Ji, Fanceng
    BMC ANESTHESIOLOGY, 2023, 23 (01)
  • [38] Esketamine as an Adjuvant to Ciprofol or Propofol Sedation for Same-Day Bidirectional Endoscopy: Protocol for a Randomized, Double-Blind, Controlled Trial With Factorial Design
    Long, Yu-Qin
    Feng, Chang-Dong
    Ding, Yun-Ying
    Feng, Xiao-Mei
    Liu, Hong
    Ji, Fu-Hai
    Peng, Ke
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [39] Efficacy and Safety of Toutongning Capsule in Patients with Migraine: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Yu, Shengyuan
    Ran, Ye
    Wan, Qi
    Yang, Xiaosu
    Chen, Huisheng
    Wang, Hebo
    Hu, Xueqiang
    Mao, Shanping
    Yu, Tingming
    Luo, Guogang
    Guan, Yangtai
    Gao, Xuguang
    Li, Xin
    Zhou, Muke
    Li, Yu
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2019, 25 (12) : 1215 - 1224
  • [40] Efficacy and Safety of Chuanxiong Qingnao Granule in Patients with Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial
    Li, Yi-Fan
    Hu, Hui-Min
    Wang, Bo-Ning
    Zhang, Yi
    Liu, Xing
    Mao, Peng
    Fan, Bi-Fa
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021